Common TitleEXPEDITION-5
Official Title Efficacy and Safety of glecaprevir/pibrentasvir in Renally Impaired Patients With Chronic HCV Infection
Phase Phase III
ClinicalTrials.gov NCT03069365
Treatments
Glecaprevir-Pibrentasvir

Glecaprevir-Pibrentasvir
Tradename:MavyretOther Names:GLE-PIBClass:FDA-ApprovedFunding
IndustryAbbVie